154 related articles for article (PubMed ID: 32272948)
1. Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules.
Ho SY; Chen PR; Chen CH; Tsai NM; Lin YH; Lin CS; Chuang CH; Huang XF; Chan YL; Liu YK; Chung CH; Weng SL; Liao KW
J Nanobiotechnology; 2020 Apr; 18(1):58. PubMed ID: 32272948
[TBL] [Abstract][Full Text] [Related]
2. A fusion protein with the receptor-binding domain of vascular endothelial growth factor-A (VEGF-A) is an antagonist of angiogenesis in cancer treatment: Simultaneous blocking of VEGF receptor-1 and 2.
Tseng FJ; Chen YC; Lin YL; Tsai NM; Lee RP; Chung YS; Chen CH; Liu YK; Huang YS; Hwang CH; Lai YK; Liao KW
Cancer Biol Ther; 2010 Nov; 10(9):865-73. PubMed ID: 20818186
[TBL] [Abstract][Full Text] [Related]
3. Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15.
Daugimont L; Vandermeulen G; Defresne F; Bouzin C; Mir LM; Bouquet C; Feron O; Préat V
Eur J Pharm Biopharm; 2011 Aug; 78(3):314-9. PubMed ID: 21316447
[TBL] [Abstract][Full Text] [Related]
4. Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies.
Lin YL; Tsai NM; Chen CH; Liu YK; Lee CJ; Chan YL; Wang YS; Chang YC; Lin CH; Huang TH; Wang CC; Chi KH; Liao KW
J Nanobiotechnology; 2019 Feb; 17(1):25. PubMed ID: 30728015
[TBL] [Abstract][Full Text] [Related]
5. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
6. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
7. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
8. Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis.
Kim WJ; Yockman JW; Lee M; Jeong JH; Kim YH; Kim SW
J Control Release; 2005 Aug; 106(1-2):224-34. PubMed ID: 15970348
[TBL] [Abstract][Full Text] [Related]
9. A fusion protein composed of receptor binding domain of vascular endothelial growth factor-A and constant region fragment of antibody: angiogenesis antagonistic activity.
Tseng FJ; Liu YK; Chung YS; Lin YL; Chen CH; Wang WY; Chen YC; Tsai NM; Cheng TL; Pan RY; Hu TM; Lee RP; Liao KW
Cytotechnology; 2011 May; 63(3):285-93. PubMed ID: 21461946
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
Yi C; Huang Y; Guo ZY; Wang SR
Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
[TBL] [Abstract][Full Text] [Related]
11. Gene therapeutic exploration: retrovirus-mediated soluble vascular endothelial growth factor receptor-2 (sFLK-1) inhibits the tumorigenicity of S180, MCF-7, and B16 cells in vivo.
Kou B; Li Y; Shi Y; Xia J; Wang X; Wu S
Oncol Res; 2005; 15(5):239-47. PubMed ID: 16261843
[TBL] [Abstract][Full Text] [Related]
12. Chimeric protein ABRaA-VEGF121 is cytotoxic towards VEGFR-2-expressing PAE cells and inhibits B16-F10 melanoma growth.
Smagur A; Boyko MM; Biront NV; Cichoń T; Szala S
Acta Biochim Pol; 2009; 56(1):115-24. PubMed ID: 19252752
[TBL] [Abstract][Full Text] [Related]
13. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells.
Lin YL; Liu YK; Tsai NM; Hsieh JH; Chen CH; Lin CM; Liao KW
Nanomedicine; 2012 Apr; 8(3):318-27. PubMed ID: 21704596
[TBL] [Abstract][Full Text] [Related]
14. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
15. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell surface display of immunoglobulin heavy chain Fc by gene transfer as a means to mimic antibody therapy.
Riddle DS; Sanz L; Chong H; Thompson J; Vile RG
Hum Gene Ther; 2005 Jul; 16(7):830-44. PubMed ID: 16000065
[TBL] [Abstract][Full Text] [Related]
17. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
[TBL] [Abstract][Full Text] [Related]
18. Antitumor Effect of
Gao HW; Chang KF; Huang XF; Lin YL; Weng JC; Liao KW; Tsai NM
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563276
[TBL] [Abstract][Full Text] [Related]
19. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
Shamay Y; Golan M; Tyomkin D; David A
J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
[TBL] [Abstract][Full Text] [Related]
20. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model.
Markov OV; Mironova NL; Shmendel EV; Serikov RN; Morozova NG; Maslov MA; Vlassov VV; Zenkova MA
J Control Release; 2015 Sep; 213():45-56. PubMed ID: 26134071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
